DIABETES MELLITUS, PERMANENT NEONATAL, 1; PNDM1

Literature (4)

Literature for OMIM 606176: DIABETES MELLITUS, PERMANENT NEONATAL, 1; PNDM1

Xenbase Articles:
(

Denotes literature images)

A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes., Proks P,Arnold AL,Bruining J,Girard C,Flanagan SE,Larkin B,Colclough K,Hattersley AT,Ashcroft FM,Ellard S, Hum Mol Genet. June 1, 2006; 15(11):1460-2083.
Xenopus as a model system for studying pancreatic development and diabetes., Kofent J,Spagnoli FM, Semin Cell Dev Biol. March 1, 2016; 51:1096-3634.
Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes., Babiker T,Vedovato N,Patel K,Thomas N,Finn R,Männikkö R,Chakera AJ,Flanagan SE,Shepherd MH,Ellard S,Ashcroft FM,Hattersley AT, Diabetologia. June 1, 2016; 59(6):1432-0428.
Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment., Misra S,Vedovato N,Cliff E,De Franco E,Hattersley AT,Ashcroft FM,Oliver NS, Diabet Med. June 13, 2018; :1464-5491.

A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes., Proks P,Arnold AL,Bruining J,Girard C,Flanagan SE,Larkin B,Colclough K,Hattersley AT,Ashcroft FM,Ellard S, Hum Mol Genet. June 1, 2006; 15(11):1460-2083.

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes., Babiker T,Vedovato N,Patel K,Thomas N,Finn R,Männikkö R,Chakera AJ,Flanagan SE,Shepherd MH,Ellard S,Ashcroft FM,Hattersley AT, Diabetologia. June 1, 2016; 59(6):1432-0428.

Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment., Misra S,Vedovato N,Cliff E,De Franco E,Hattersley AT,Ashcroft FM,Oliver NS, Diabet Med. June 13, 2018; :1464-5491.